血液型タイピング市場：技術、検査タイプ、製品タイプ、エンドユーザー別-2025-2030年の世界予測

血液型タイピング市場は、2023年に33億7,000万米ドルと評価され、2024年には36億3,000万米ドルに達すると予測され、CAGR 7.82%で成長し、2030年には57億2,000万米ドルに達すると予測されています。

血液型タイピングは、個人の血液型とRh因子を決定する重要な診断プロセスであり、安全な輸血、臓器移植、出生前ケアに不可欠です。この手順は、緊急医療、日常ヘルスケア、研究において極めて重要であり、生命を脅かす可能性のある免疫反応を防ぐために適合性を保証します。血液型タイピング市場は、血液の安全性に関する意識の高まり、外科手術の増加、慢性疾患の蔓延などにより拡大しており、信頼性の高い血液検査に対する需要を牽引しています。自動タイピングシステムやデジタルタイピングシステムなどの大幅な技術進歩により、スピードと精度が向上し、これが重要な促進要因となっています。さらに、新興国におけるヘルスケア・インフラへの投資の拡大は、市場拡大の機会をもたらしています。人口の高齢化と輸血を必要とする疾患の増加も、市場の需要を増大させています。しかし市場は、高度なタイピングシステムの高コスト、規制上のハードル、熟練技術者の必要性といった課題に直面しています。費用対効果に優れ、使いやすい技術やしっかりとした研修プログラムを開発することで、こうした制約に対処することが、さらなる成長を促進する可能性があります。ポイントオブケア検査装置、予測分析のためのAIとの統合、個別化医療ソリューションなどの革新は、有望な研究分野を表しています。さらに、普遍的な代替血液の創出に向けた研究開発努力の強化は、この分野に革命をもたらす可能性があります。教育キャンペーンを通じて認知度を高めるためにヘルスケアプロバイダーと協力することも、市場の成長を促進する可能性があります。逆に、低所得地域における認知度の低さ、偽陰性の可能性、技術的な複雑さが課題となっています。こうしたハードルにもかかわらず、技術革新とヘルスケア・アクセスの拡大が市場の成長を後押ししています。研究開発への戦略的投資、技術統合に焦点を当てたパートナーシップ、新興市場の潜在力の活用が、血液型タイピングの機会を生かす鍵となると思われます。

市場力学：急速に進化する血液型タイピング市場の主要市場インサイトを公開

血液型タイピング市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 交通事故、緊急事態、外傷の増加
  • 法医学における血液型タイピング採用の増加
  • 輸血に関する厳しい規制基準
• 市場抑制要因
  • 認識と熟練した専門家の不足
• 市場機会
  • 血液型タイピングシステムの進歩と開発
  • 血液型タイピングの研究開発活動と製品イノベーションの増加
• 市場の課題
  • トランスミッションに関連するリスク

ポーターのファイブフォース：血液型タイピング市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、血液型タイピング市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：血液型タイピング市場における外部からの影響の把握

外部マクロ環境要因は、血液型タイピング市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析血液型タイピング市場における競合情勢の把握

血液型タイピング市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス血液型タイピング市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、血液型タイピング市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨血液型タイピング市場における成功への道筋を描く

血液型タイピング市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 交通事故、緊急事態、外傷の増加
    • 法医学における血液型タイピングの採用増加
    • 輸血に関する厳格な規制基準
  • 抑制要因
    • 認識と熟練した専門家の欠如
  • 機会
    • 血液型タイピングシステムの進歩と発展
    • 血液型タイピングにおける研究開発活動と製品イノベーションの強化
  • 課題
    • 伝染病に伴うリスク
• 市場セグメンテーション分析
  • 技術：アッセイベースおよび大規模並列シーケンス技術の採用の増加
  • 検査の種類：抗原を検出するためのABO血液検査とヒト白血球抗原タイピング検査の急速な出現
  • 製品：血液型タイピングサービスにおける消耗品および器具の重要な使用
  • エンドユーザー：臨床検査室や病院における血液型タイピングサービスの新たな利用
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 血液型タイピング市場テクニック

• アッセイベースの技術
• 超並列シーケンシング
• マイクロアレイ

第7章 血液型タイピング市場テストタイプ別

• ABO血液検査
• 抗体スクリーニング
• 抗原型判定
• クロスマッチングシリーズ
• ヒト白血球抗原タイピング

第8章 血液型タイピング市場：製品別

• 消耗品
• 機器
• サービス

第9章 血液型タイピング市場：エンドユーザー別

• 血液銀行
• 臨床検査室
• 病院

第10章 南北アメリカの血液型タイピング市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の血液型タイピング市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの血液型タイピング市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • My Personal Health BankがEldon Biologicals A/Sと提携し、POC血液型検査を組み込んだ革新的なヘルスケアソリューションを提供
  • メトロポリス・ヘルスケアがHSCTと固形臓器移植の検査を開始
  • NHSBTの研究者が新しい血液型システムを発見
• 戦略分析と提言

企業一覧

• Agena Bioscience, Inc.
• Atlas Medical GmbH
• AXO Science SAS
• BAG Health Care GmbH
• Beckman Coulter, Inc.
• Bio-Rad Laboratories, Inc
• Biorex Diagnostics
• Cardinal Health
• Genome Diagnostics B.V.
• Grifols, S.A.
• Hemo bioscience, Inc.
• Lorne Laboratories Limited
• Merck KGaA
• Quotient Suisse SA
• Rapid Labs Ltd
• Thermo Fisher Scientific, Inc.

LIST OF FIGURES

• FIGURE 1. BLOOD GROUP TYPING MARKET RESEARCH PROCESS
• FIGURE 2. BLOOD GROUP TYPING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BLOOD GROUP TYPING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. BLOOD GROUP TYPING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. BLOOD GROUP TYPING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BLOOD GROUP TYPING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BLOOD GROUP TYPING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BLOOD GROUP TYPING MARKET DYNAMICS
• TABLE 7. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY ASSAY-BASED TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY MASSIVELY PARALLEL SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY ABO BLOOD TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY ANTIBODY SCREENING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY ANTIGEN TYPING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY CROSS-MATCHING SERIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY HUMAN LEUKOCYTE ANTIGEN TYPING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. CANADA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 39. CANADA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 40. CANADA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. CANADA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 58. AUSTRALIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. AUSTRALIA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. CHINA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 61. CHINA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 62. CHINA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. CHINA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. INDIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 65. INDIA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 66. INDIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. INDIA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 70. INDONESIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. INDONESIA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 74. JAPAN BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. JAPAN BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 78. MALAYSIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. MALAYSIA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 82. PHILIPPINES BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. PHILIPPINES BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 86. SINGAPORE BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. SINGAPORE BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH KOREA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH KOREA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 94. TAIWAN BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. TAIWAN BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 98. THAILAND BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. THAILAND BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 102. VIETNAM BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. VIETNAM BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 111. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 115. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 119. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 123. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 124. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 127. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 131. ISRAEL BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. ISRAEL BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. ITALY BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 134. ITALY BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 135. ITALY BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 136. ITALY BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 139. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 140. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 143. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 147. NORWAY BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 148. NORWAY BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 149. POLAND BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 150. POLAND BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 151. POLAND BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 152. POLAND BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 153. QATAR BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 154. QATAR BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 155. QATAR BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 156. QATAR BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 159. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 160. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 164. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 168. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 171. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 172. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 175. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 176. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 179. SWITZERLAND BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 180. SWITZERLAND BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 183. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 184. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 188. UNITED ARAB EMIRATES BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 192. UNITED KINGDOM BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 193. BLOOD GROUP TYPING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 194. BLOOD GROUP TYPING MARKET, FPNV POSITIONING MATRIX, 2023

The Blood Group Typing Market was valued at USD 3.37 billion in 2023, expected to reach USD 3.63 billion in 2024, and is projected to grow at a CAGR of 7.82%, to USD 5.72 billion by 2030.

Blood group typing is a critical diagnostic process that determines an individual's blood type and Rh factor, essential for safe blood transfusions, organ transplants, and prenatal care. This procedure is crucial in medical emergencies, routine healthcare, and research, ensuring compatibility to prevent potentially life-threatening immune responses. The market for blood group typing is expanding due to rising awareness about blood safety, increased surgical procedures, and chronic disease prevalence, which drive the demand for reliable blood testing. Significant technological advancements, such as automated and digital typing systems, enhance speed and accuracy, which are critical growth drivers. Moreover, growing investments in healthcare infrastructure in emerging economies present opportunities for market expansion. The aging population, coupled with increasing cases of disorders requiring blood transfusions, also augments market demand. However, the market faces challenges like high costs of advanced typing systems, regulatory hurdles, and the need for skilled technicians. Addressing these constraints by developing cost-effective, user-friendly technologies and robust training programs could foster further growth. Innovations such as point-of-care testing devices, integration with AI for predictive analytics, and personalized medical solutions represent promising research areas. Additionally, increased R&D efforts towards creating universal blood alternatives could revolutionize the field. Collaborating with healthcare providers to enhance awareness through education campaigns may also promote market growth. Conversely, limited awareness in low-income regions, potential for false negatives, and technical complexities pose challenges. Despite these hurdles, the market is poised for growth, driven by technological innovations and expanding healthcare access. Strategic investments in R&D, partnerships focusing on technological integration, and harnessing emerging market potentials will be key to capitalizing on the opportunities in blood group typing.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood Group Typing Market

The Blood Group Typing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing cases of road accidents, emergencies, and trauma
  • Rising adoption of blood group typing in forensic sciences
  • Strict regulatory standards regarding blood transfusion
• Market Restraints
  • Lack of awareness and skilled professional
• Market Opportunities
  • Advancements and developments in the blood group typing systems
  • Increasing R&D activities and product innovations in blood group typing
• Market Challenges
  • Risk associated with transmissible diseases

Porter's Five Forces: A Strategic Tool for Navigating the Blood Group Typing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood Group Typing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood Group Typing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood Group Typing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood Group Typing Market

A detailed market share analysis in the Blood Group Typing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood Group Typing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood Group Typing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Blood Group Typing Market

A strategic analysis of the Blood Group Typing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Blood Group Typing Market, highlighting leading vendors and their innovative profiles. These include Agena Bioscience, Inc., Atlas Medical GmbH, AXO Science SAS, BAG Health Care GmbH, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc, Biorex Diagnostics, Cardinal Health, Genome Diagnostics B.V., Grifols, S.A., Hemo bioscience, Inc., Lorne Laboratories Limited, Merck KGaA, Quotient Suisse SA, Rapid Labs Ltd, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Blood Group Typing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Techniques, market is studied across Assay-Based Techniques, Massively Parallel Sequencing, and Microarray.
• Based on Test Type, market is studied across ABO Blood Tests, Antibody Screening, Antigen Typing, Cross-Matching Series, and Human Leukocyte Antigen Typing.
• Based on Product, market is studied across Consumables, Instruments, and Services.
• Based on End-User, market is studied across Blood Banks, Clinical Laboratories, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing cases of road accidents, emergencies, and trauma
    • 5.1.1.2. Rising adoption of blood group typing in forensic sciences
    • 5.1.1.3. Strict regulatory standards regarding blood transfusion
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of awareness and skilled professional
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements and developments in the blood group typing systems
    • 5.1.3.2. Increasing R&D activities and product innovations in blood group typing
  • 5.1.4. Challenges
    • 5.1.4.1. Risk associated with transmissible diseases
• 5.2. Market Segmentation Analysis
  • 5.2.1. Techniques: Increasing adoption of assay-based and massively Parallel Sequencing techniques
  • 5.2.2. Test Type: Rapid emergence of ABO blood tests and human leukocyte antigen typing tests to detect the antigens
  • 5.2.3. Product: Significant use of consumables and instruments in blood group typing services
  • 5.2.4. End-User: Emerging use of blood group typing services in clinical laboratories and hospitals
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Blood Group Typing Market, by Techniques

• 6.1. Introduction
• 6.2. Assay-Based Techniques
• 6.3. Massively Parallel Sequencing
• 6.4. Microarray

7. Blood Group Typing Market, by Test Type

• 7.1. Introduction
• 7.2. ABO Blood Tests
• 7.3. Antibody Screening
• 7.4. Antigen Typing
• 7.5. Cross-Matching Series
• 7.6. Human Leukocyte Antigen Typing

8. Blood Group Typing Market, by Product

• 8.1. Introduction
• 8.2. Consumables
• 8.3. Instruments
• 8.4. Services

9. Blood Group Typing Market, by End-User

• 9.1. Introduction
• 9.2. Blood Banks
• 9.3. Clinical Laboratories
• 9.4. Hospitals

10. Americas Blood Group Typing Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Blood Group Typing Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Blood Group Typing Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. My Personal Health Bank Joins Forces with Eldon Biologicals A/S for Innovative Healthcare Solutions incorporating POC Blood Typing
  • 13.3.2. Metropolis Healthcare launches test for HSCT & solid organ transplantation
  • 13.3.3. NHSBT Researchers Discover New Blood Group System
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agena Bioscience, Inc.
• 2. Atlas Medical GmbH
• 3. AXO Science SAS
• 4. BAG Health Care GmbH
• 5. Beckman Coulter, Inc.
• 6. Bio-Rad Laboratories, Inc
• 7. Biorex Diagnostics
• 8. Cardinal Health
• 9. Genome Diagnostics B.V.
• 10. Grifols, S.A.
• 11. Hemo bioscience, Inc.
• 12. Lorne Laboratories Limited
• 13. Merck KGaA
• 14. Quotient Suisse SA
• 15. Rapid Labs Ltd
• 16. Thermo Fisher Scientific, Inc.